·
1 Min Read

AMA statement on federal grant terminations for mental health, SUD care

The AMA is deeply concerned about the termination of federal grant funding for programs that support substance use disorder and mental health care.

Press Releases

Membership Moves Medicine™

  • Thousands of free CME opportunities to fulfill state requirements
  • A powerful voice fighting for you during uncertain times
  • Research, resources, events and more from the largest physician organization
Supportive group holding hands
·
5 Min Read

Time for decisive action on substance-use disorder treatment

Progress is being made to prevent overdose deaths, but about 75,000 lives are still lost annually. The AMA outlines aggressive steps to save more lives.

Behavioral Health
Two colleagues in conversation
UPDATED
·
2 Min Read

Physicians’ progress toward ending the nation’s drug overdose epidemic

Learn more about physicians’ actions toward ending the nation’s overdose epidemic and improving care for patients with pain and substance use disorders (SUD). Download PDF of the Substance Use and Treatment Report.

Behavioral Health
·
3 Min Read

AMA 2025 report on substance use and treatment

New report shows drop in overdose deaths and calls on policymakers to remove obstacles to evidence-based care. 

Press Releases
Doctor prescribing pharmacy to patient
·
4 Min Read

Cross DEA training requirement off your final-year residency checklist

Before you transition to practice, you must complete your MATE Act-required DEA training. An AMA Ed Hub course is tailored for your needs.

series
Transition to Attending
Transitioning to Practice
Person colored with bright psychedelic paint
·
4 Min Read

Nonclinical psilocybin use soars. What should be done now?

A JAMA Psychiatry study shows a sharp increase in use of psilocybin mushrooms. Learn more, plus discover what interests you from across the JAMA Network.

Publications & Newsletters
·
4 Min Read

Top news stories from AMA Morning Rounds®: Week of Oct. 27, 2025

In the news: Stillbirths more common in U.S. than previously reported, GLP-1s show promise in treating substance use disorders and more. 

Publications & Newsletters
·
1 Min Read

Oct. 24, 2025: State Advocacy Update

New issue brief provides kratom and tianeptine basics, AMA recommendations, and more in the latest State Advocacy Update.

Advocacy Update
UPDATED
·
3 Min Read

Public health: CSAPH reports

Download PDFs of reports on this topic for the Council on Science and Public Health (CSAPH) presented during the AMA Interim and Annual Meetings.

Science & Public Health